Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
0.9000
+0.0001 (0.01%)
At close: Nov 11, 2026, 4:00 PM EST
0.9300
+0.0300 (3.33%)
After-hours: Nov 11, 2026, 4:49 PM EST
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $88.93 million as of November 11, 2026. Its market cap has decreased by 55.67% in one year.
Market Cap
88.93M
Enterprise Value
63.04M
1-Year Change
-55.67%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $88.93M, a decrease of -88.08%. That is a compound annual growth rate of -32.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 88.93M | -56.91% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | -26.92% |
| Jul 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Owlet | 127.96M |
| Apyx Medical | 123.84M |
| Pulmonx | 120.64M |
| MaxCyte | 115.59M |
| Perspective Therapeutics | 91.23M |
| Sera Prognostics | 80.48M |
| Lucid Diagnostics | 77.77M |
| Outset Medical | 77.57M |